Biomedicine & Pharmacotherapy (Oct 2023)
Corrigendum to “Tegaserod maleate exhibits antileukemic activity by targeting TRPM8” [Biomed. Pharmacother. 154 (2022) 113566]
- Xiaoling Xie,
- Wanwen Yang,
- Wuju Zhang,
- Yingqi Qiu,
- Zeyou Qiu,
- Hao Wang,
- Yuxing Hu,
- Yuhua Li,
- Xuan Zhou,
- Luyao Li,
- Zhuanzhuan Chen,
- Chenbo Zhao,
- Yao Lu,
- Keqin Zhang,
- Eryong Lai,
- Xiaochun Bai
Affiliations
- Xiaoling Xie
- Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde Foshan), Foshan 528308, China; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China
- Wanwen Yang
- Guangdong Provincial Key Laboratory of Bone and Joint Degenerative Diseases, Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China
- Wuju Zhang
- Guangdong Provincial Key Laboratory of Bone and Joint Degenerative Diseases, Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China
- Yingqi Qiu
- Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China
- Zeyou Qiu
- Guangdong Provincial Key Laboratory of Bone and Joint Degenerative Diseases, Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China
- Hao Wang
- Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China
- Yuxing Hu
- Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China
- Yuhua Li
- Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China; Department of Basic Research & International Cooperation, Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou 510005, China
- Xuan Zhou
- Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China
- Luyao Li
- Guangdong Provincial Key Laboratory of Bone and Joint Degenerative Diseases, Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China
- Zhuanzhuan Chen
- Guangdong Provincial Key Laboratory of Bone and Joint Degenerative Diseases, Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China
- Chenbo Zhao
- Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China
- Yao Lu
- Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China
- Keqin Zhang
- Department of Oncology, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou 510999, China; Correspondence to: Department of Oncology, The Fifth Affiliated Hospital of Southern Medical University, No. 566, Congcheng Avenue, Conghua District, Guangzhou 510999, China.
- Eryong Lai
- Department of Oncology, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou 510999, China; Correspondence to: Department of Oncology, The Fifth Affiliated Hospital of Southern Medical University, No. 566, Congcheng Avenue, Conghua District, Guangzhou 510999, China.
- Xiaochun Bai
- Guangdong Provincial Key Laboratory of Bone and Joint Degenerative Diseases, Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China; Correspondence to: Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Shatai Nan Road 1023-1063, Baiyun District, Guangzhou 510515, China.
- Journal volume & issue
-
Vol. 166
p. 115378
